James Bluhm, DPM
Foot Surgery · Corpus Christi, TXNPI 1699774463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 28.0% of the total. Reporting peaked in 2023 at $390 and has fallen 90.0% since, to $39 in 2025. That places this record below the midpoint for foot surgery clinicians in TX, where the typical reported total is $2,095.
Across 18 payments — averaging $45.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$229
- Acumed LLC$210
- Kerecis Limited$185
- Stryker$96
- Triad Life Sciences Inc.$56
- Urgo Medical North America, LLC$15
- plus $24 from 2 others
What the payments were for
- Food & beverage$815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 2 | $229 |
| Acumed LLC | 3 | $210 |
| Kerecis Limited | 2 | $185 |
| Stryker | 4 | $96 |
| Triad Life Sciences Inc. | 3 | $56 |
| Urgo Medical North America, LLC | 1 | $15 |
| Biocomposites Inc | 1 | $12 |
| Reprise Biomedical, Inc. | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$815 in reported general payments places this provider in the 25th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 127 | $8,952 |
| Clotrimazole | 113 | $1,139 |
| Cephalexin | 61 | $418 |
| Terbinafine Hcl | 17 | $356 |
| Ciprofloxacin Hcl | 11 | $146 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $134 |
| Clindamycin Hcl | 14 | $95 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Corpus Christi
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
- Richard GalperinDallas$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.